Overview

3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars

Status:
Not yet recruiting

Trial end date:
2024-08-01

Target enrollment:

Participant gender:

Summary

This randomized clinical study aims to assess the clinical and radiographic success rate of the 3Mixtatin versus the 3Mix in LSTR in necrotic primary molars.

Phase:

N/A

Details

Lead Sponsor:

Cairo University

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular
Simvastatin